Extramedullary sudden blast crisis in chronic-phase chronic myeloid leukemia during first-line treatment with nilotinib

Detalles Bibliográficos
Autores principales: Angelopoulou, M K, Asimakopoulos, J V, Galani, Z, Levidou, G, Roumelioti, M, Vassilakopoulos, T P, Korkolopoulou, P, Panayiotidis, P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5022179/
https://www.ncbi.nlm.nih.gov/pubmed/27564459
http://dx.doi.org/10.1038/bcj.2016.66
_version_ 1782453472165101568
author Angelopoulou, M K
Asimakopoulos, J V
Galani, Z
Levidou, G
Roumelioti, M
Vassilakopoulos, T P
Korkolopoulou, P
Panayiotidis, P
author_facet Angelopoulou, M K
Asimakopoulos, J V
Galani, Z
Levidou, G
Roumelioti, M
Vassilakopoulos, T P
Korkolopoulou, P
Panayiotidis, P
author_sort Angelopoulou, M K
collection PubMed
description
format Online
Article
Text
id pubmed-5022179
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-50221792016-09-20 Extramedullary sudden blast crisis in chronic-phase chronic myeloid leukemia during first-line treatment with nilotinib Angelopoulou, M K Asimakopoulos, J V Galani, Z Levidou, G Roumelioti, M Vassilakopoulos, T P Korkolopoulou, P Panayiotidis, P Blood Cancer J Letter to the Editor Nature Publishing Group 2016-08 2016-08-26 /pmc/articles/PMC5022179/ /pubmed/27564459 http://dx.doi.org/10.1038/bcj.2016.66 Text en Copyright © 2016 The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Letter to the Editor
Angelopoulou, M K
Asimakopoulos, J V
Galani, Z
Levidou, G
Roumelioti, M
Vassilakopoulos, T P
Korkolopoulou, P
Panayiotidis, P
Extramedullary sudden blast crisis in chronic-phase chronic myeloid leukemia during first-line treatment with nilotinib
title Extramedullary sudden blast crisis in chronic-phase chronic myeloid leukemia during first-line treatment with nilotinib
title_full Extramedullary sudden blast crisis in chronic-phase chronic myeloid leukemia during first-line treatment with nilotinib
title_fullStr Extramedullary sudden blast crisis in chronic-phase chronic myeloid leukemia during first-line treatment with nilotinib
title_full_unstemmed Extramedullary sudden blast crisis in chronic-phase chronic myeloid leukemia during first-line treatment with nilotinib
title_short Extramedullary sudden blast crisis in chronic-phase chronic myeloid leukemia during first-line treatment with nilotinib
title_sort extramedullary sudden blast crisis in chronic-phase chronic myeloid leukemia during first-line treatment with nilotinib
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5022179/
https://www.ncbi.nlm.nih.gov/pubmed/27564459
http://dx.doi.org/10.1038/bcj.2016.66
work_keys_str_mv AT angelopouloumk extramedullarysuddenblastcrisisinchronicphasechronicmyeloidleukemiaduringfirstlinetreatmentwithnilotinib
AT asimakopoulosjv extramedullarysuddenblastcrisisinchronicphasechronicmyeloidleukemiaduringfirstlinetreatmentwithnilotinib
AT galaniz extramedullarysuddenblastcrisisinchronicphasechronicmyeloidleukemiaduringfirstlinetreatmentwithnilotinib
AT levidoug extramedullarysuddenblastcrisisinchronicphasechronicmyeloidleukemiaduringfirstlinetreatmentwithnilotinib
AT roumeliotim extramedullarysuddenblastcrisisinchronicphasechronicmyeloidleukemiaduringfirstlinetreatmentwithnilotinib
AT vassilakopoulostp extramedullarysuddenblastcrisisinchronicphasechronicmyeloidleukemiaduringfirstlinetreatmentwithnilotinib
AT korkolopouloup extramedullarysuddenblastcrisisinchronicphasechronicmyeloidleukemiaduringfirstlinetreatmentwithnilotinib
AT panayiotidisp extramedullarysuddenblastcrisisinchronicphasechronicmyeloidleukemiaduringfirstlinetreatmentwithnilotinib

Ejemplares similares